Alzheimer
Disease (AD)
Epidemiology and
Etiology:
·
Most common cause of dementia in the elderly
·
40% prevalence in 85-90y cohort
·
Rarely symptomatic before 50y
·
Sporadic mostly
·
5-10% familial
·
Trisomy 21
·
Nearly 100% over age 45y
·
APP is on chromosome 21
·
May result in overexpression and
subsequent production of Aß
·
Aß is thought to be
a critical molecule in the pathogenesis
·
Derived from cleavage of APP by beta- and gamma- secretase
Common sites:
·
Earliest (stages I,II):
·
Entorhinal cortex (at uncus) (anterior of hippocampus – squiggly part)
·
Then (stages III, IV):
·
Hippocampal formation
·
Latest (stages V, VI)
·
Neocortex / isocortex (take a section at the occipital pole with
striate and peristriate cortex)
·
Sparing of primary motor and sensory cortex
Gross features:
·
Cortical atrophy
·
Widening of gyri
·
Most pronounced frontal, temporal, parietal
·
Ventricular enlargement
Histologic
features:
·
Neuritic (senile) plaques
·
20-200 um diameter
·
Spherical collections of dilated, tortuous, silver-staining neuritic processes
·
Central amyloid core often
·
Surrounded by a clear halo maybe
·
Microglia and reactive astrocytes at
the periphery
·
Neurofibrillary tangles
·
Bundles of filaments in the neuron cytoplasm that displace or
encircle the nucleus
·
Tau protein is a major component
·
Basophilic fibrillary structures on
H&E
·
Silver (Bielchowsky) stain positive
·
Remain after death of neuron
·
Not specific to Alzheimer
·
Braak staging:
·
Stage I,II (transentorhinal):
·
Involvement only of transentorhinal
cortex (see above)
·
Stage III, IV (limbic):
·
Severe involvement of transentorhinal
cortex
·
Moderate involvement of CA1 of hippocampus
·
None to mild involvement of isocortex
·
Stage V, VI:
·
Moderate involvement of peristriate,
then striate cortex
·
Neuronal loss
·
Glial reaction
·
Amyloid angiopathy
·
Almost invariably accompanies Alzheimer
·
Granulovacuolar degeneration
·
Clear intraneuronal cytoplasmic
vacuoles
·
Argyrophilic granule within
each one
·
Hirano bodies
·
Elongated, glassy, eosinophilic bodies
·
Actin is major
component
Immunophenotype:
Marker: |
Sensitivity: |
Specificity: |
Congo red (core
of neuritic plaques) |
|
|
Aß (core of neuritic plaques) |
|
|
Amyloid precursor
protein (APP) |
|
|
Silver (Bielchowsky) (neurofibrillary
tangles) |
|
|
Tau protein (neurofibrillary tangles) |
|
|
MAP2 (neurofibrillary tangles) |
|
|
Ubiquitin (neurofibrillary tangles) |
|
|
Molecular features:
·
Familial AD (5-10%):
·
APP gene mutations on chromosome 21
·
Result in increased Aß
·
Presenilin-1 (PS1) mutations
·
Component of gamma-secretase
·
Presenilin-2 (PS2) mutations
·
Component of gamma-secretase
·
Epsilon-4 allele of apolipoprotein E (ApoE)
·
Presence of this allele increases risk and lowers age of onset
Other features:
·
EM
·
Neurofibrillary tangles:
·
Paired helical filaments
·
Some straight filaments
·
Number of neurofibrillary tangles
correlates better with degree of dementia than number of neuritic
plaques
·
Transentorhinal stage:
·
Preclinical
·
Isocortical stage:
·
Fully developed AD
References:
·
Kumar V, Fausto N, Abbas
A. Robbins & Cotran Pathologic Basis of Disease,
Seventh Edition. 7th ed. Saunders; 2004.
·
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239-59.